http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010034854-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1fd716ba2ec9eeccfafa1048dc19a2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_099d28ebd7d65e9faf7d7d24e0ccb45b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-205 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-02 |
| filingDate | 2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d53761c9467b90016d833faf1845b20b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63250fca10934afd08a293d3b7d51ac0 |
| publicationDate | 2010-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2010034854-A1 |
| titleOfInvention | Electroimmunisation chamber |
| abstract | The invention relates to a horizontal chamber for treating patients suffering from the human immunodeficiency virus HIV. The patients position themselves in a supine decubitus position, and the chamber has a cover in the upper part thereof, at a variable height, comprising a magnetic pulse generator. Furthermore, electrodes are arranged in the area occupied by the patient, said electrodes being fixed in the lower area and variable in the upper area of the patient's body, generating electrical impulses complementing the magnetic impulses. The control and regulation mechanisms of the chamber ensure a certain dosage of electromagnetic energy acting on the ionic channels of the protein GP120 present in the human immunodeficiency virus HIV, which open up and lose the necessary energy used to interact with the CD4 receptors that are marker molecules in the cellular surface and recognise certain antibodies. |
| priorityDate | 2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.